| 0478U | Oncology (non-small cell lung cancer), DNA and RNA, digital PCR analysis of 9 genes (EGFR, KRAS, BRAF, ALK, ROS1, RET, NTRK1/2/3, ERBB2, and MET) in FFPE tissue |
| 0485U | Oncology (solid tumor), cell-free DNA and RNA by NGS, interpretative report for germline mutations, clonal hematopoiesis of indeterminate potential, and tumor-derived SNVs, indels, CNAs, fusions, MSI, and TMB |
| 0486U | Oncology (pan-solid tumor), NGS analysis of tumor methylation markers in cfDNA, algorithm reported as quantitative methylation correlate of tumor fraction |
| 0487U | Oncology (solid tumor), ctDNA targeted genomic sequence panel of 84 genes, sequence variants, copy number, rearrangements, MSI |
| 0496U | Oncology (colorectal), cfDNA, 8 genes for mutations, 7 genes for methylation, and 4 proteins by ELISA, blood; reported positive/negative for colorectal cancer or advanced adenoma risk |
| 0497U | Oncology (prostate), mRNA gene-expression profiling by RT-PCR of 6 genes in FFPE, risk score |
| 0498U | Oncology (colorectal), NGS for mutation detection in 43 genes and methylation pattern in 45 genes, blood and FFPE tissue |
| 0499U | Oncology (colorectal and lung), DNA from FFPE tissue, NGS of 8 genes (NRAS, EGFR, CTNNB1, PIK3CA, APC, BRAF, KRAS, ...) |
| 0501U | Oncology (colorectal), blood, quantitative measurement of cfDNA |
| 0507U | Oncology (ovarian), DNA whole-genome sequencing with 5-hydroxymethylcytosine enrichment, whole blood or plasma, algorithm reported as cancer detected or not |